Related Articles
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion
Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma
Urokinase-type plasminogen activator system and breast cancer (Review)